Emergence Therapeutics Funding: $94M Raised, Series A (2021)
Emergence Therapeutics is based in Marseille, France. It has raised $94M in total funding. Latest round: Series A.
Emergence Therapeutics funding overview
Emergence Therapeutics is based in Marseille, France. Emergence Therapeutics has raised $94M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in December 2021. The round record for Emergence Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Pontifax Venture Capital, RA Capital Management, OrbiMed Advisors, Surveyor Capital, Hadean Ventures, Kurma Partners and 4 others. 10 distinct backers are named across the disclosed rounds.
Emergence Therapeutics at a glance
Total raised
$94M
Latest round
Series A
Latest round date
December 2021
Headquarters
Marseille, France
Notable investors
Pontifax Venture Capital, RA Capital Management, OrbiMed Advisors, Surveyor Capital, Hadean Ventures, Kurma Partners, NRW.BANK, High-Tech Gründerfonds
Frequently asked about Emergence Therapeutics funding
How much has Emergence Therapeutics raised?
Emergence Therapeutics has raised $94M in total disclosed funding across the rounds on record.
Who has invested in Emergence Therapeutics?
Pontifax Venture Capital, RA Capital Management, OrbiMed Advisors, Surveyor Capital, Hadean Ventures, Kurma Partners are named among the investors backing Emergence Therapeutics.
What was the latest Emergence Therapeutics funding round?
The most recent disclosed round is a Series A, announced in December 2021.
Where is Emergence Therapeutics based?
Emergence Therapeutics is based in Marseille, France.
When did Emergence Therapeutics last raise?
The last disclosed Emergence Therapeutics round closed in December 2021 at Series A.
Every Emergence Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Marseille at a similar stage.
